Polar Vantage Accuracy: More Published Studies Than Almost Any

A 2021 study measured the Vantage V2 against a reference heart-rate sensor in 39 participants lying down in a lab and 29 participants sleeping at home, plus a pooled dataset of over 11,000 individual pulse intervals. Heart rate agreement was excellent: no difference from the reference in the lab, and a small 0.7 bpm underestimate overnight, with an intraclass correlation of 0.998 for nocturnal recordings.

HRV, measured as log-transformed RMSSD, showed the same very strong nocturnal correlation (intraclass correlation 0.931) but a real and specific bias: the watch systematically overestimated it in both settings (mean bias 0.20 ms in the lab, 0.17 ms overnight), and that overestimation grew larger the lower a person's actual HRV was. The authors' own conclusion is precise: adequate accuracy for recreational athletes, with the caveat that anyone relying on strict absolute values, rather than tracking their own trend over time, should know about the low-HRV bias specifically.

A 2025 study measured heart rate from a wrist-worn Vantage V2 and an upper-arm Polar Verity Sense across nine activities, from lying down to high-intensity interval training, in 16 healthy adults, against a Polar H10 chest strap as reference. The Verity Sense was excellent everywhere (systematic bias −0.05 bpm, 1.35 percent mean absolute percentage error, perfect concordance). The wrist-worn Vantage V2 was moderate by comparison: a 2.56 bpm overestimate on the nondominant wrist, 6.82 percent mean absolute percentage error, and reliability that varied enormously by activity, from 3.64 percent variation after exercise while sitting to 23.03 percent while lying down.

The direction is worth noting: the Vantage V2's accuracy got better, not worse, as intensity rose, outperforming several other wrist-worn devices from prior research during vigorous activity even though it struggled more at rest and at low heart rates. For anyone choosing between Polar's own wrist watch and its upper-arm sensor, the arm-worn Verity Sense was the more accurate of the two in this study.

A 2022 free-living study of 21 adults compared a Polar Vantage watch and an Oura ring against a 7-day sleep diary, alongside research-grade ActiGraph and Actiheart monitors for activity and heart rate. Polar-derived sleep duration correlated strongly with the diary (r=0.74), a similar result to the Oura ring tested alongside it (r=0.82), and the authors concluded both devices could potentially replace a manual sleep diary depending on how much error a given use case can tolerate.

That study measured duration, not the stage breakdown (light, deep, REM) Sleep Plus reports, but Polar's staging has been tested: in a 2022 sleep-lab comparison of six devices, the Polar Vantage V agreed with polysomnography on sleep versus wake 87 percent of the time (kappa 0.44) and on specific stages 51 percent of the time (kappa 0.28), and the authors concluded all six devices need improvement for stage assessment. That lab receives research support from WHOOP, one of the other devices tested (Sensors, 2022 [conflict statement: the authors' lab receives funding and equipment from WHOOP]).

A 2025 study validated the resting Polar Fitness Test against cardiopulmonary exercise testing, the clinical gold standard, in patients undergoing medically supervised exercise training. It found 13.7 percent mean absolute percentage error and an intraclass correlation coefficient of 0.743, a real but moderate level of agreement for an estimate that requires no exercise at all.

What that result does not settle is how the estimate behaves outside a supervised-training population. The published record located for this page tests the Fitness Test in adults in clinical exercise settings; it does not establish accuracy for athletes training at the top of their range, for adolescents, or for anyone with a congenital cardiac condition. Treat the number as a trend line for a trained adult rather than a substitute for formal testing, which is also the cited study's own framing.

No independent validation of Recovery Pro as a composite score turned up in this search that could be independently re-verified. Two ResearchGate-hosted studies on the underlying orthostatic-test protocol are named on this page as sources, but their DOIs could not be located, so their specific findings are not restated here as verified.

What that leaves is the HRV-at-rest evidence reviewed above, which is directly relevant since the Orthostatic Test measures RMSSD in exactly the lying-down and standing conditions that study examined. That evidence found adequate HRV accuracy with a specific overestimation bias at low HRV values. Whether Recovery Pro's own scoring of that data tracks actual recovery status is untested on the record this search could verify.

Nothing. No independent study of Training Load Pro's cardio-load or muscular-load scoring turned up in this search.

Energy-expenditure evidence does exist for Polar's underlying accuracy in general: a 2024 study found a Polar Vantage M2's estimated energy expenditure was reliable but not statistically valid against a metabolic reference during pickleball play, and a 2023 study found the same model reliable for energy expenditure during walking and jogging but invalid during overground skipping. Neither tests Training Load Pro's own scoring, only the raw energy-expenditure signal it likely draws from.

A dedicated search for independent validation of the Vantage wrist-ECG feature, or of any accuracy or arrhythmia-detection figure for it, returned nothing. Polar itself does not market the feature for AFib detection, so there is no vendor-claimed accuracy figure to check it against either.